Targeting glutamine metabolism network for the treatment of therapy-resistant prostate cancer.
Xu L, Zhao B, Butler W, Xu H, Song N, Chen X, Spencer Hauck J, Gao X, Zhang H, Groth J, Yang Q, Zhao Y, Moon D, George D, Zhou Y, He Y, Huang J.
Xu L, et al. Among authors: zhao y, zhao b.
Oncogene. 2022 Feb;41(8):1140-1154. doi: 10.1038/s41388-021-02155-z. Epub 2022 Jan 20.
Oncogene. 2022.
PMID: 35046532
Free PMC article.